Related Experiment Videos

[Should we treat all diabetic patients with aspirin in primary prevention?]

A Righetti1, P De Moerloose, J Philippe

  • 1Service d'endocrinologie, diabétologie et nutrition, Hôpitaux universitaires de Genève, 1211 Genève 14. anne.righetti@hcuge.ch

Revue Medicale Suisse
|July 20, 2005
PubMed

Insights

Patients with diabetes face increased risks of atherothrombotic disease, including coronary artery disease. While aspirin is recommended for cardiovascular prevention, its effectiveness in primary prevention for diabetics remains inconclusive, warranting cautious recommendations.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Context:

  • Diabetes mellitus significantly elevates atherothrombotic disease risk, with up to a fourfold increase in coronary artery disease.
  • Atherothrombotic disease represents a major cause of morbidity and mortality in diabetic populations worldwide.
  • Cardiovascular disease prevention is a critical aspect of diabetes management.

Purpose:

  • To evaluate the efficacy of aspirin in the primary prevention of cardiovascular events among patients with diabetes.
  • To synthesize evidence from interventional studies examining aspirin use in diabetic individuals for primary prevention.
  • To provide an evidence-based perspective on current guidelines regarding aspirin for diabetic patients.

Summary:

  • Aspirin is a widely used medication for cardiovascular disease prevention.
  • Interventional studies on aspirin for primary prevention in diabetic patients show mixed and inconclusive results.
  • Current guidelines, including those from the American Diabetes Association, suggest a role for aspirin, but evidence is not definitive.

Impact:

  • Highlights the need for individualized risk assessment in prescribing aspirin for primary prevention in diabetes.
  • Suggests that current recommendations for aspirin in diabetic primary prevention require careful consideration due to inconclusive evidence.
  • Emphasizes the importance of further research to clarify the role of aspirin in this high-risk population.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...